802NP301 Efficacy and Safety Study of BIIB074 in Participants With Trigeminal Neuralgia

NCT03070132 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor Decision

Conditions

Trigeminal Neuralgia

Interventions

DRUG: BIIB074
DRUG: Placebo

Sponsor

Biogen